Chemical Pathology Directorate
Box 14 Rundle Mall Post Office
Adelaide SA 5000 - Australia
Prof. Howard Morris (PhD, FAACB, FFSc(RCPA)) holds a joint appointment as Professor of Medical Science in the School of Pharmacy and Medical Sciences, University of South Australia and Clinical Scientist in Chemical Pathology at SA Pathology, Adelaide Australia. Between 2012 and 2014 he served as IFCC Vice-president, between 2003 and 2008 he was the Secretary of the Scientific Division of the IFCC and has served as Chair the IFCC-International Osteoporosis Foundation Joint WG on Standardization of Bone Turnover Markers (2012-2017) and as a member of the IFCC Task Forces on the Global Campaign on Diabetes Mellitus (2003- 2008) and on International Clinical Liaison (2009-2011).
Within the Asia Pacific Federation of Clinical Biochemistry (APFCB) he served as Chair, Scientific Committee (2002-2004) and Chair, Scientific Organising Committee, Member Organising Committee for 10th Asian Pacific Congress of Clinical Biochemistry (2002-2005). He was the Australasian Association of Clinical Biochemists (AACB) representative to the Councils of the IFCC and APFCB (1998-2004), served on AACB Council (1998-2002) and Editor of the Clinical Biochemist Reviews (1994-2002). He was awarded an AACB Outstanding Service Medallion (2003) and the W. Roman Travelling Lectureship (2004). Dr Morris is currently a Clinical Scientist in the Chemical Pathology Directorate, SA Pathology providing clinical advice and comments in the discipline. He has 30 years’ experience working in diagnostic clinical biochemistry in the field of immunoassay and endocrinology including management of a major clinical endocrinology laboratory. In 1997/98, the laboratory reported some 245,000 patient results. Between 2003 and 2009 he was the Director of the Hanson Institute, the research arm of the IMVS and RAH. In 2009 the Hanson Institute administered infrastructure to support the research of some 300 staff and 100 postgraduate students who generated external grants amounting to approximately $AUD 30 million annually.
Professor Morris leads an active research team that has received over $10 million in competitive research grants and has published 280 refereed publications, reviews and book chapters. His research interest includes the pathophysiology of metabolic bone disease and the effects of hormones including vitamin D funded by the National Health and Medical Research Council and Australian Research Council, the major competitive funding bodies in Australia. His latest work has identified anabolic actions of vitamin D following metabolism within bone tissue providing a molecular mechanism for vitamin D requirement to reduce the risk of fractures amongst the elderly. He was awarded the Louis Avioli Memorial Lectureship for 2009 by the American Society for Bone and Mineral Research on this topic.
Prof. Howard Morris passed away in April 2019, while in Kazakhstan where he was lecturing as an IFCC Visiting Lecturer.